For GBM, LUAD, PRAD, LIHC, READ, and UCS, studies have shown that lncRNA FEZF1-AS1 plays a crucial regulatory role in them (Luo et al., 2020; Liu et al., 2018; Zhu et al., 2019; Wang et al., 2018; Bian et al., 2018; Zhang and Li, 2018). Here, FEZF1 is linked to glioblastoma.